Docusign Q4 Beat Underpins Cash Flow but Growth Acceleration Awaits ARR Guidance

What happened

Docusign reported Q4 FY26 results that exceeded expectations, with strong annual recurring revenue (ARR) and a 25% year-over-year surge in free cash flow to $350 million, highlighting operational efficiency. Subscription revenue grew 8% year-over-year with stable 83.4% gross margins, reinforcing business resilience amid competitive pressures from Adobe and Microsoft. These outcomes align with the DeepValue report's focus on Intelligent Agreement Management (IAM) adoption, which has scaled to over 25,000 customers, but the market remains skeptical about sustained growth above high-single digits. Despite the beat, the stock's historical decline of about 25% over the past year reflects investor fatigue with mere earnings surprises without clear ARR re-acceleration. The upcoming disclosure of ARR and IAM metrics in the earnings call will be critical to validate whether Docusign can transition from a stable cash generator to a growth re-accelerator.

Implication

Investors should note that Docusign's robust free cash flow generation, with margins expanding to 42%, supports continued share buybacks and per-share value accretion, providing a downside cushion. However, with revenue growth stuck at 8%, the stock trades at a premium multiple that assumes future acceleration, which remains unproven without ARR guidance above 10%. The imminent FY27 ARR and IAM disclosures will serve as a litmus test; if they indicate meaningful upsell and adoption, the bull case for multiple expansion strengthens, but if they disappoint, downside risks from competitive bundling could materialize. Critical monitoring points include any signs of pricing pressure or churn in enterprise segments, as highlighted in the DeepValue report's bear scenario. Therefore, while the Q4 beat is positive, investors should maintain a cautious stance, avoiding overexposure until ARR trends confirm the re-acceleration narrative.

Thesis delta

The Q4 results do not shift the core investment thesis, which already anticipated strong cash flow and IAM traction as key drivers. They reinforce the margin of safety from operational efficiency but leave the growth acceleration component unchanged, pending the ARR guidance update. Thus, the thesis remains a potential buy with conviction hinging on whether FY27 ARR guidance meets or exceeds 10%, as outlined in the base and bull scenarios.